ICUI vs PATH
ICU Medical Inc (ICUI) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
ICU Medical Inc (ICUI) is a medical instruments & supplies company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ICUI revenue for 2024-12-31 was $2.38B. Net income was -$117.7M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ICUI currently screens at market cap $3.45B and trailing P/E 73.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ICUI and PATH stock pages for the full models.
Not investment advice.